Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
01/2005
01/05/2005CN1559520A Chinese medicinal preparation for preventing and curing enteric disease of animal and paultory and its preparation method
01/05/2005CN1559517A Globeflover new medicinal preparation-globeflower disperstion tablet more suitable for child and aged
01/05/2005CN1559510A Compound medicine for treating Aids, cancer and its preparation method
01/05/2005CN1559488A Medicinal tea of infused in boiling water and its production method
01/05/2005CN1559482A Preparation method of achillea effective part medicinal preparation
01/05/2005CN1559480A Oral liquid for treating virus coryza and throat disease and its preparation technology
01/05/2005CN1559473A Cinnamon twig decoction drop pill and its preparation method
01/05/2005CN1559472A Astragalus injection Chinese medicinal preparation and its preparation method
01/05/2005CN1559470A Chinese patent drug for livestock
01/05/2005CN1559463A Medicine for treating viral hepatitis B
01/05/2005CN1559461A External use Chinese herb medicinal mixture for treating mumps
01/05/2005CN1559459A Traditional Chinese medicine capsule for treating tuberculosis and neo-last-cough
01/05/2005CN1559456A Traditional Chinese medicinal prepn.-defervescent capsule for treating presistent febris during common cold, and prepn. method therefor
01/05/2005CN1559451A Medicine compound having synergistic action
01/05/2005CN1559448A Traditional Chinese medicine for treating tuberculosis, and its prepn. method
01/05/2005CN1559441A Method for preparing immune milk anti-pathogenic microoganism in digestive tract
01/05/2005CN1559438A Medicine for treating tinea pedis, and prepn. method
01/05/2005CN1559433A Polyhexose type nanometer antimicrobial matter, prepn. method and use thereof
01/05/2005CN1559431A Disperse tablet contg. klinemycin hydrochloride palmitate, and its prepn. method
01/05/2005CN1559430A Prepn. of large volume infusion contg. Xi-Duo-Fu-Wei
01/05/2005CN1559429A Freezing-drying powder injectiong contg. Xi-Duo-Fu-Wei
01/05/2005CN1559428A Complex medicine for eliminating pyloric spirillar bacilli contg. secnidazole
01/05/2005CN1559425A Method for preparing Baicalin prepn. for external use
01/05/2005CN1559422A Oral medicine for eliminating pyloric spirillar bacilli
01/05/2005CN1559411A Application of stable thiabutyldine quinoline carboxylate in preparing anti-infective
01/05/2005CN1559410A Itraconazole soft capsule, and its prepn. method
01/05/2005CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former
01/05/2005CN1559400A Method for preparing scutellarein liquid
01/05/2005CN1559398A Application of chalcone for preparing medicnes for treating hepatitis and hepatoma
01/05/2005CN1183151C Spherical telithroimycikn clusters, method for the production and use thereof in the preparation of pharmaceutical forms
01/05/2005CN1183142C Cynnematin kind antibiotics and composite and use
01/05/2005CN1183141C Vinyl-pyrrolidone cynnematin with alkali substituent
01/05/2005CN1183136C Indoloquinazolinones
01/05/2005CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors
01/05/2005CN1182868C Mutent enterotoxin effective as non-toxic oral adjuvant
01/05/2005CN1182860C Medicines for treating hepatitis B and preparation thereof
01/05/2005CN1182855C Dog pestilence treating medicine composition
01/05/2005CN1182854C Chinese medicine liquor for curing pointed condyloma and its preparation method
01/05/2005CN1182853C Application of medicinal material resisting against human cytomegalvovirus
01/05/2005CN1182851C Compound extracted from effective part of influenze virus resisting medicine
01/05/2005CN1182848C Application of brataxin in preparation of medicine for inhibiting AIDS virus
01/05/2005CN1182842C Soft gelatin capsule and its manufacture method
01/05/2005CN1182831C Synergistic antibacterial combination
01/04/2005US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C
01/04/2005US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and
01/04/2005US6838472 Substituted urea retinoid agonists
01/04/2005US6838466 Compounds for the treatment of inflammatory disorders
01/04/2005US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles
01/04/2005US6838435 Grampositive, gramnegative bacteria; bactericides, fungicides; antibiotic resistance
01/04/2005US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase
01/04/2005US6838269 Comprises reduced allergenic variant of enzymatic polypeptide for use in textile treatment and cleaning composition and animal feeds; antiallergens
01/04/2005US6838095 Substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent.
01/04/2005US6838093 System for osmotic delivery of pharmaceutically active agents
01/04/2005US6838089 Vaccines; immunogens; for Helicobacter infections
01/04/2005US6838084 For connection with major histomcompatability complex molecules
01/04/2005CA2432972A1 Sushi peptides, processes for making and uses thereof
01/04/2005CA2283509C Novel bicyclonucleoside and oligonucleotide analogue
01/04/2005CA2093076C 2- and 3-amino and azido derivatives of 1,5-iminosugars
12/2004
12/30/2004US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
12/30/2004US20040267015 Bactericides
12/30/2004US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
12/30/2004US20040267011 Methods for synthesis of diarylmethanes
12/30/2004US20040267010 For therapy of central nervous system disorders
12/30/2004US20040266998 6,11-4-Carbon bridged ketolides
12/30/2004US20040266888 Composition for treatment of infections of humans and animals
12/30/2004US20040266853 Small molecule antiproliferative agents
12/30/2004US20040266844 Antimicrobial and radioprotective compounds
12/30/2004US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
12/30/2004US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors
12/30/2004US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
12/30/2004US20040266817 3-Substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents
12/30/2004US20040266805 Inflammation modulatory compound
12/30/2004US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta
12/30/2004US20040266778 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
12/30/2004US20040266764 Hydroxamic acid derivatives
12/30/2004US20040266756 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a][1,4] benzodiazepines
12/30/2004US20040266750 Beta-lactamyl vasopressin v1aantagonists
12/30/2004US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
12/30/2004US20040266723 Antiviral agents for treatment of Flaviviridae infections
12/30/2004US20040266722 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
12/30/2004US20040266720 Splice-region antisense composition and method
12/30/2004US20040266719 immunostimulatory CpG oligonucleotide for inducing a mucosal immune response for treating a subject having an infection comprising enterovirus, calciviridae, vesicular stomatitis, rotavirus infection, Salmonella spp. infection, Helicobacter pyloris infection and M. intracellulare infection
12/30/2004US20040266710 Immunotherapy; induce immunology response
12/30/2004US20040266709 Immunotherapy; induction immunology response
12/30/2004US20040266702 Topical treatment or prevention of ocular infections
12/30/2004US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents
12/30/2004US20040266667 Streptogramin derivatives, preparation method and compositions containing same
12/30/2004US20040266666 Cross-linked glycopeptide-cephalosporin antibiotics
12/30/2004US20040266634 Adhesion inhibition of moulds
12/30/2004US20040266008 Obtained by cultivation of Streptomyces melanosporafaciens; biosynthesis; fungicides; antitumor agents; antiproliferative agents
12/30/2004US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography
12/30/2004US20040265968 Tissue plasminogen activator-like protease
12/30/2004US20040265936 In gram-negative host cells; immunogenic epitopes from herpes virus; cytokines; interleukins; interferons; tumour necrosis factors; solid phase synthesis; homologous recombination
12/30/2004US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells
12/30/2004US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis
12/30/2004US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents
12/30/2004US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells
12/30/2004US20040265866 Receptor on the surface of activated T-cells: ACT-4
12/30/2004US20040265427 Novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
12/30/2004US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery